Conference item

Phase 1 study of HSP90 inhibitor ganetespib with pemetrexed and cisplatin/carboplatin chemotherapy for pleural mesothelioma

Publication status:: Published

Peer review status:: Reviewed (other)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Fennell, D., Danson, S., Forster, M., Talbot, D., Woll, P., Child, J., Ngai, Y., Farrelly, L., Hackshaw, A., Sharkey, A., Busacca, S., Hastings, R., Barnes, D., Nicolson, M., Taylor, P., Ahmed, S., & Wheeler, G. (2018). Phase 1 study of HSP90 inhibitor ganetespib with pemetrexed and cisplatin/carboplatin chemotherapy for pleural mesothelioma. Journal of Thoracic Oncology, 13(10), S397–S397.

MLA Style

Fennell, D., et al. “Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma.” Journal of Thoracic Oncology, vol. 13, no. 10, Elsevier, 2018, pp. S397–S397.

Chicago Style

Fennell, D, S Danson, M Forster, D Talbot, P Woll, J Child, Y Ngai, et al. 2018. “Phase 1 Study of HSP90 Inhibitor Ganetespib with Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma.” In Journal of Thoracic Oncology, 13:S397–S397. Elsevier.
Tweet
Print

Access Document

Publisher copy:: 10.1016/j.jtho.2018.08.415

Authors

+ Fennell, D More by this author

Role:

Author

+ Danson, S More by this author

Role:

Author

+ Forster, M More by this author

Role:

Author

+ Talbot, D More by this author

Institution:

University of Oxford

Division:

MSD

Department:

Oncology

Role:

Author

ORCID:

0000-0002-0183-0642

+ Woll, P More by this author

Role:

Author

More authors...

Bibliographic Details

Publisher:: Elsevier
Host title:: Journal of Thoracic Oncology
Journal:: Journal of Thoracic Oncology More from this journal
Volume:: 13
Issue:: 10
Pages:: S397-S397
Publication date:: 2018-10-22
DOI:: 10.1016/j.jtho.2018.08.415
EISSN:: 1556-1380
ISSN:: 1556-0864

Item Description

Language:: English
Keywords:: pleural mesothelioma

FFR

dose-escalation

HSP90 inhibition
Pubs id:: 958270
Local pid:: pubs:958270
Deposit date:: 2020-06-08

Terms of use

Copyright holder:: Elsevier Inc.
Copyright date:: 2018
Rights statement:: Copyright © 2018 Published by Elsevier Inc.

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Metrics

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP